{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:16:35Z","timestamp":1792736195608,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,29]],"date-time":"2017-07-29T00:00:00Z","timestamp":1501286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,7,29]],"date-time":"2017-07-29T00:00:00Z","timestamp":1501286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR055957"],"award-info":[{"award-number":["R01AR055957"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13104-017-2674-x","type":"journal-article","created":{"date-parts":[[2017,7,29]],"date-time":"2017-07-29T12:07:29Z","timestamp":1501330049000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Authentication of collagen VI antibodies"],"prefix":"10.1186","volume":"10","author":[{"given":"Jamie","family":"Endicott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Holden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5346-5379","authenticated-orcid":false,"given":"Jamie","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,29]]},"reference":[{"key":"2674_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/483531a","volume":"483","author":"CG Begley","year":"2012","unstructured":"Begley CG, Ellis LM. Drug development: raise standards for preclinical cancer research. Nature. 2012;483:531\u20133.","journal-title":"Nature"},{"key":"2674_CR2","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1074\/mcp.R800013-MCP200","volume":"7","author":"L Berglund","year":"2008","unstructured":"Berglund L, Bjorling E, Oksvold P, Fagerberg L, Asplund A, Szigyarto CA, Persson A, Ottosson J, Wernerus H, Nilsson P, et al. A genecentric Human Protein Atlas for expression profiles based on antibodies. Mol Cell Proteom. 2008;7:2019\u201327.","journal-title":"Mol Cell Proteom"},{"key":"2674_CR3","doi-asserted-by":"publisher","first-page":"20170","DOI":"10.1074\/jbc.M710139200","volume":"283","author":"J Fitzgerald","year":"2008","unstructured":"Fitzgerald J, Rich C, Zhou FH, Hansen U. Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI). J Biol Chem. 2008;283:20170\u201380.","journal-title":"J Biol Chem"},{"key":"2674_CR4","doi-asserted-by":"publisher","first-page":"10658","DOI":"10.1074\/jbc.M709540200","volume":"283","author":"SK Gara","year":"2008","unstructured":"Gara SK, Grumati P, Urciuolo A, Bonaldo P, Kobbe B, Koch M, Paulsson M, Wagener R. Three novel collagen VI chains with high homology to the alpha3 chain. J Biol Chem. 2008;283:10658\u201370.","journal-title":"J Biol Chem"},{"key":"2674_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrneurol.2011.81","volume":"7","author":"CG Bonnemann","year":"2011","unstructured":"Bonnemann CG. The collagen VI-related myopathies: muscle meets its matrix. Nat Rev Neurol. 2011;7:379\u201390.","journal-title":"Nat Rev Neurol"},{"key":"2674_CR6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/jmg.2002.002311","volume":"42","author":"AK Lampe","year":"2005","unstructured":"Lampe AK, Bushby KM. Collagen VI related muscle disorders. J Med Genet. 2005;42:673\u201385.","journal-title":"J Med Genet"},{"key":"2674_CR7","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1002\/humu.22429","volume":"34","author":"RJ Butterfield","year":"2013","unstructured":"Butterfield RJ, Foley AR, Dastgir J, Asman S, Dunn DM, Zou Y, Hu Y, Donkervoort S, Flanigan KM, Swoboda KJ, et al. Position of glycine substitutions in the triple helix of COL6A1, COL6A2, and COL6A3 is correlated with severity and mode of inheritance in collagen VI myopathies. Hum Mutat. 2013;34:1558\u201367.","journal-title":"Hum Mutat"},{"key":"2674_CR8","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1074\/jbc.M109932200","volume":"277","author":"SR Lamande","year":"2002","unstructured":"Lamande SR, Morgelin M, Selan C, Jobsis GJ, Baas F, Bateman JF. Kinked collagen VI tetramers and reduced microfibril formation as a result of Bethlem myopathy and introduced triple helical glycine mutations. J Biol Chem. 2002;277:1949\u201356.","journal-title":"J Biol Chem"},{"key":"2674_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/hmg\/ddi025","volume":"14","author":"NL Baker","year":"2005","unstructured":"Baker NL, Morgelin M, Peat R, Goemans N, North KN, Bateman JF, Lamande SR. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. Hum Mol Genet. 2005;14:279\u201393.","journal-title":"Hum Mol Genet"},{"key":"2674_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/ana.21213","volume":"62","author":"NL Baker","year":"2007","unstructured":"Baker NL, Morgelin M, Pace RA, Peat RA, Adams NE, Gardner RJ, Rowland LP, Miller G, De Jonghe P, Ceulemans B, et al. Molecular consequences of dominant Bethlem myopathy collagen VI mutations. Ann Neurol. 2007;62:390\u2013405.","journal-title":"Ann Neurol"},{"key":"2674_CR11","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.1074\/jbc.M114.632208","volume":"290","author":"LK Zamurs","year":"2015","unstructured":"Zamurs LK, Idoate MA, Hanssen E, Gomez-Ibanez A, Pastor P, Lamande SR. Aberrant mitochondria in a Bethlem myopathy patient with a homozygous amino acid substitution that destabilizes the collagen VI alpha2(VI) chain. J Biol Chem. 2015;290:4272\u201381.","journal-title":"J Biol Chem"},{"key":"2674_CR12","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/hmg\/7.6.981","volume":"7","author":"SR Lamande","year":"1998","unstructured":"Lamande SR, Bateman JF, Hutchison W, McKinlay Gardner RJ, Bower SP, Byrne E, Dahl HH. Reduced collagen VI causes Bethlem myopathy: a heterozygous COL6A1 nonsense mutation results in mRNA decay and functional haploinsufficiency. Hum Mol Genet. 1998;7:981\u20139.","journal-title":"Hum Mol Genet"},{"key":"2674_CR13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/humu.20704","volume":"29","author":"AK Lampe","year":"2008","unstructured":"Lampe AK, Zou Y, Sudano D, O\u2019Brien KK, Hicks D, Laval SH, Charlton R, Jimenez-Mallebrera C, Zhang RZ, Finkel RS, et al. Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance. Hum Mutat. 2008;29:809\u201322.","journal-title":"Hum Mutat"},{"key":"2674_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1086\/377107","volume":"73","author":"TC Pan","year":"2003","unstructured":"Pan TC, Zhang RZ, Sudano DG, Marie SK, Bonnemann CG, Chu ML. New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype. Am J Hum Genet. 2003;73:355\u201369.","journal-title":"Am J Hum Genet"},{"key":"2674_CR15","doi-asserted-by":"publisher","first-page":"8011","DOI":"10.1074\/jbc.L115.639088","volume":"290","author":"P Sabatelli","year":"2015","unstructured":"Sabatelli P, Gualandi F, Bonaldo P, Merlini L. Detecting collagen VI in Bethlem myopathy. J Biol Chem. 2015;290:8011.","journal-title":"J Biol Chem"},{"key":"2674_CR16","doi-asserted-by":"publisher","first-page":"8012","DOI":"10.1074\/jbc.L115.641175","volume":"290","author":"SR Lamande","year":"2015","unstructured":"Lamande SR. Reply to Sabatelli et al.: detecting collagen VI in Bethlem myopathy. J Biol Chem. 2015;290:8012.","journal-title":"J Biol Chem"},{"key":"2674_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1074\/jbc.M008173200","volume":"276","author":"J Fitzgerald","year":"2001","unstructured":"Fitzgerald J, Morgelin M, Selan C, Wiberg C, Keene DR, Lamande SR, Bateman JF. The N-terminal N5 subdomain of the alpha 3(VI) chain is important for collagen VI microfibril formation. J Biol Chem. 2001;276:187\u201393.","journal-title":"J Biol Chem"},{"key":"2674_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1042\/bj2110303","volume":"211","author":"H Furthmayr","year":"1983","unstructured":"Furthmayr H, Wiedemann H, Timpl R, Odermatt E, Engel J. Electron-microscopical approach to a structural model of intima collagen. BiochemJ. 1983;211:303\u201311.","journal-title":"BiochemJ"},{"key":"2674_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1749-6632.1985.tb51154.x","volume":"460","author":"J Engel","year":"1985","unstructured":"Engel J, Furthmayr H, Odermatt E, von der Mark H, Aumailley M, Fleischmajer R, Timpl R. Structure and macromolecular organization of type VI collagen. Ann NY Acad Sci. 1985;460:25\u201337.","journal-title":"Ann NY Acad Sci"},{"key":"2674_CR20","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1083\/jcb.107.5.1995","volume":"107","author":"DR Keene","year":"1988","unstructured":"Keene DR, Engvall E, Glanville RW. Ultrastructure of type VI collagen in human skin and cartilage suggests an anchoring function for this filamentous network. J Cell Biol. 1988;107:1995\u20132006.","journal-title":"J Cell Biol"},{"key":"2674_CR21","doi-asserted-by":"crossref","unstructured":"Hessle H, Engvall E: Type VI collagen. Studies on its localization, structure, and biosynthetic form with monoclonal antibodies. JBiolChem 1984, 259:3955-3961.","DOI":"10.1016\/S0021-9258(17)43189-9"},{"key":"2674_CR22","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1212\/01.wnl.0000327611.01687.5e","volume":"71","author":"L Merlini","year":"2008","unstructured":"Merlini L, Martoni E, Grumati P, Sabatelli P, Squarzoni S, Urciuolo A, Ferlini A, Gualandi F, Bonaldo P. Autosomal recessive myosclerosis myopathy is a collagen VI disorder. Neurology. 2008;71:1245\u201353.","journal-title":"Neurology"},{"key":"2674_CR23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.nmd.2006.07.015","volume":"16","author":"C Jimenez-Mallebrera","year":"2006","unstructured":"Jimenez-Mallebrera C, Maioli MA, Kim J, Brown SC, Feng L, Lampe AK, Bushby K, Hicks D, Flanigan KM, Bonnemann C, et al. A comparative analysis of collagen VI production in muscle, skin and fibroblasts from 14 Ullrich congenital muscular dystrophy patients with dominant and recessive COL6A mutations. Neuromuscul Disord. 2006;16:571\u201382.","journal-title":"Neuromuscul Disord"},{"key":"2674_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/518027a","volume":"518","author":"A Bradbury","year":"2015","unstructured":"Bradbury A, Pluckthun A. Reproducibility: standardize antibodies used in research. Nature. 2015;518:27\u20139.","journal-title":"Nature"},{"key":"2674_CR25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.12688\/f1000research.2-153.v1","volume":"2","author":"MA Helsby","year":"2013","unstructured":"Helsby MA, Fenn JR, Chalmers AD. Reporting research antibody use: how to increase experimental reproducibility. F1000Res. 2013;2:153.","journal-title":"F1000Res"},{"key":"2674_CR26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1210\/en.2012-2222","volume":"154","author":"AC Gore","year":"2013","unstructured":"Gore AC. Editorial: antibody validation requirements for articles published in endocrinology. Endocrinology. 2013;154:579\u201380.","journal-title":"Endocrinology"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-017-2674-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-017-2674-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-017-2674-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T16:17:01Z","timestamp":1659284221000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-017-2674-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,29]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2674"],"URL":"https:\/\/doi.org\/10.1186\/s13104-017-2674-x","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,29]]},"assertion":[{"value":"19 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"358"}}